An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.
暂无分享,去创建一个
Yan Liu | Huamin Wang | Haojie Huang | B. Ji | C. Logsdon | Baoan Ji | Z. Cruz-Monserrate | D. Deng | Huamin Wang | Sebastian Gaiser | Craig D Logsdon | Haojie Huang | Defeng Deng | Zobeida Cruz-Monserrate | J. Daniluk | Jaroslaw Daniluk | Jun Chu | S. Gaiser | J. Chu | Yan Liu | Jun Chu | Defeng Deng
[1] S. Pandol,et al. Early NF-κB activation is associated with hormone-induced pancreatitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[2] Xinghua Lu,et al. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer. , 2002, Chinese medical journal.
[3] E. Ranheim,et al. Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. , 2011, Blood.
[4] G. Green,et al. Interaction of dietary protein and trypsin inhibitor on plasma cholecystokinin and pancreatic growth in rats. , 1986, Advances in experimental medicine and biology.
[5] B. Ji,et al. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] K. Guan,et al. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini. , 1995, The American journal of physiology.
[7] I. Goldfine,et al. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. , 1985, The Journal of clinical investigation.
[8] M. Korc,et al. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. , 2009, Biochemical and biophysical research communications.
[9] S. Dey,et al. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. , 2005, Cancer research.
[10] Judith Campisi,et al. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.
[11] Y. Motoo. Antiproteases in the treatment of chronic pancreatitis. , 2007, JOP : Journal of the pancreas.
[12] B. Ji,et al. Robust acinar cell transgene expression of CreErT via BAC recombineering , 2008, Genesis.
[13] A. Levitzki,et al. Residues crucial for Ras interaction with GDP-GTP exchangers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] Lewis A. Chodosh,et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.
[15] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[16] T. Ishikawa,et al. Transgenic mouse for conditional, tissue‐specific Cox‐2 overexpression , 2006, Genesis.
[17] T. Wirth,et al. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. , 2007, The Journal of clinical investigation.
[18] C. Der,et al. Guanine nucleotide exchange factors: Activators of Ras superfamily proteins , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[19] C. Lang,et al. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[20] Huamin Wang,et al. Ras activity levels control the development of pancreatic diseases. , 2009, Gastroenterology.
[21] D. Tuveson,et al. RAS in cellular transformation and senescence. , 2009, European journal of cancer.
[22] Jen Jen Yeh,et al. Targeting signal transduction in pancreatic cancer treatment , 2007, Expert opinion on therapeutic targets.
[23] John A. Williams,et al. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice , 2004 .
[24] G. Manes,et al. Helicobacter pylori and pancreatic disease. , 2003, JOP : Journal of the pancreas.
[25] A. Dabrowski,et al. Calcineurin-dependent and Calcineurin-independent Signal Transduction Pathways Activated as Part of Pancreatic Growth , 2006, Pancreas.
[26] B. Göke,et al. Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis , 2009 .
[27] T. Jacks,et al. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Owen,et al. Ras binding to a C‐terminal region of GAP , 1995, FEBS letters.
[29] P. Treuting,et al. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. , 2006, Cancer research.
[30] M. Karin,et al. Loss of Ikkβ Promotes Migration and Proliferation of Mouse Embryo Fibroblast Cells* , 2006, Journal of Biological Chemistry.
[31] C. Qian,et al. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. , 2004, Blood.
[32] M. Korc,et al. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. , 1978, The American journal of physiology.
[33] C. Niederau,et al. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. , 1987, Gut.
[34] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[35] Manuel Serrano,et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.
[36] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[38] H. Reber,et al. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. , 2007, Cancer research.
[39] F. Meng,et al. K-RAS mutation in the screening, prognosis and treatment of cancer. , 2009, Biomarkers in medicine.
[40] G. Gurda,et al. Regulator of calcineurin 1 controls growth plasticity of adult pancreas. , 2010, Gastroenterology.
[41] Z. Ronai,et al. High frequency of K‐ras mutations in normal appearing lung tissues and sputum of patients with lung cancer , 1995, International journal of cancer.
[42] D. Coppola,et al. IκB Kinase ε expression in pancreatic ductal adenocarcinoma. , 2011, American journal of clinical pathology.
[43] W. Greenhalf,et al. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. , 2005, Gastroenterology.
[44] D. Lowy,et al. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. , 1988, Science.
[45] J. Downward,et al. Many faces of Ras activation. , 2008, Biochimica et biophysica acta.
[46] C. Verbeke,et al. Cyclooxygenase-2 Expression Associated with Severity of PanIN Lesions: A Possible Link between Chronic Pancreatitis and Pancreatic Cancer , 2005, Pancreatology.
[47] Jicheng Li,et al. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. , 2003, World journal of gastroenterology.